This topic contains a solution. Click here to go to the answer

Author Question: During fiberoptic bronchoscopy, a patient receiving intravenous fentanyl exhibits signs of ... (Read 22 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
During fiberoptic bronchoscopy, a patient receiving intravenous fentanyl exhibits signs of respir-atory depression. Which of the following would you recommend?
 
  a. Increase the oxygen flow rate and contin-ue monitoring.
  b. Immediately administer naloxone (Nar-can).
  c. Decrease the oxygen flow rate and con-tinue monitoring.
  d. Immediately administer neostigmine or prostigmine.

Question 2

Equipment required for patient support and monitoring during a fiberoptic bronchoscopy proce-dure includes which of the following?
 
  1. Pulse oximeter
  2. Oxygen cannula
  3. Electrocardiographi c monitor
  4. Capnometer
  a. 1 and 3 only
  b. 1, 2, and 3 only
  c. 3 and 4 only
  d. 2, 3, and 4 only



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

randomguy133

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

ANS: B
Of course, caution must be taken to avoid respiratory depression. Should it occur, naloxone (Narcan) must be available.

Answer to Question 2

ANS: B




go.lag

  • Member
  • Posts: 667
Reply 2 on: Jul 16, 2018
:D TYSM


hollysheppard095

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Excellent

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Always store hazardous household chemicals in their original containers out of reach of children. These include bleach, paint, strippers and products containing turpentine, garden chemicals, oven cleaners, fondue fuels, nail polish, and nail polish remover.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

For a complete list of videos, visit our video library